文献速递关节外科

维生素E掺杂内衬在全髋关节置换术中的翻修风险:来自丹麦髋关节置换登记处的结局

Revision Risk of Total Hip Arthroplasty With Vitamin E Doped Liners: Results From the Danish Hip Arthroplasty Register.
PubMed 文献 · J Arthroplasty · 2022-02-09

基于丹麦髋关节置换登记处2008年1月1日至2019年6月30日的全国性人群研究,纳入53842例全髋关节置换术(VEPE内衬5069例,XLPE内衬48773例),比较维生素E掺杂交联聚乙烯(VEPE)内衬与交联退火或重熔聚乙烯(XLPE)内衬的翻修风险;结果显示VEPE内衬因聚乙烯相关终点翻修的风险低于XLPE(HR 0.60,95%CI 0.36-0.98),但术后3个月内全因翻修风险及无菌性松动、假体周围骨折翻修风险升高。

要点

  • VEPE内衬因聚乙烯相关终点翻修风险低于XLPE(HR 0.60,95%CI 0.36-0.98)。
  • VEPE内衬术后3个月内全因翻修风险升高(HR 1.62,95%CI 1.36-1.94)。
  • VEPE内衬术后3个月内无菌性松动翻修(HR 4.46,95%CI 2.26-8.80)和假体周围骨折翻修(HR 2.57,95%CI 1.98-3.33)风险升高。

核心结论

  • VEPE内衬因聚乙烯相关终点翻修的风险低于XLPE,但术后3个月内全因翻修风险高于XLPE。

研究设计与样本

  • 全国性人群-based登记研究,纳入丹麦髋关节置换登记处2008年1月1日至2019年6月30日期间使用非骨水泥髋臼杯、VEPE或XLPE内衬及金属或陶瓷股骨头的全髋关节置换术。
  • 共评估110803例全髋关节置换术,最终纳入53842例(46645例患者):VEPE内衬5069例(9.4%),XLPE内衬48773例(91.6%)。
  • VEPE内衬中位观察时间5.48年(四分位距3.80-7.15),XLPE内衬中位观察时间4.85年(四分位距2.68-7.76)。

主要发现

  • VEPE内衬因聚乙烯相关终点翻修的风险低于XLPE(HR 0.60,95%CI 0.36-0.98)。
  • VEPE内衬术后3个月内全因翻修风险高于XLPE(HR 1.62,95%CI 1.36-1.94)。
  • VEPE内衬术后3个月内记录为无菌性松动的翻修风险高于XLPE(HR 4.46,95%CI 2.26-8.80)。
  • VEPE内衬术后3个月内假体周围骨折翻修风险高于XLPE(HR 2.57,95%CI 1.98-3.33)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitamin E-doped cross-linked polyethylene (VEPE) liners were introduced in total hip arthroplasty (THA) to reduce wear and risk of aseptic loosening and liner fracture. We report this nationwide population-based study to investigate the safety of VEPE liners for THA compared to cross-linked annealed or remelted polyethylene (XLPE). METHODS: We included THAs from The Danish Hip Arthroplasty Register from January 1, 2008 to June 30, 2019, with uncemented cup, VEPE or XLPE liner, and metal or ceramic head. The outcome was revision due to (1) polyethylene-related endpoints (aseptic loosening, granuloma, osteolysis, or liner fractures) and (2) other endpoints. RESULTS: A total of 110,803 THAs were assessed for eligibility and 53,842 THAs (46,645 patients) were included in the study: 5069 (9.4%) THAs with a VEPE liner and 48,773 (91.6%) with a XLPE liner. Median observation time was 5.48 (interquartile range 3.80-7.15) years for VEPE and 4.85 (interquartile range 2.68-7.76) for XLPE. VEPE had a lower risk of revision for polyethylene-related endpoints compared to XLPE (hazard ratio [HR] 0.60, 95% confidence interval 0.36-0.98) during complete follow-up. THAs with VEPE liners were associated with increased risk of any revision within the first 3 months (HR 1.62, 1.36-1.94), revision recorded as aseptic loosening within 3 months (HR 4.46, 2.26-8.80), and periprosthetic fracture within 3 months (HR 2.57, 1.98, 3.33). CONCLUSION: VEPE liners had a lower risk of revision due to polyethylene-related endpoints, but a higher risk of all-cause revision within 3 months.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kjærgaard K, Varnum C, Ding M, et al. Revision Risk of Total Hip Arthroplasty With Vitamin E Doped Liners: Results From the Danish Hip Arthroplasty Register. J Arthroplasty. 2022. PMID: 35149169. doi:10.1016/j.arth.2022.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。